...
首页> 外文期刊>Cellular Oncology: Analytical Cellular Pathology >miR-142-3p Modulates Cell Invasion and Migration via PKM2-Mediated Aerobic Glycolysis in Colorectal Cancer
【24h】

miR-142-3p Modulates Cell Invasion and Migration via PKM2-Mediated Aerobic Glycolysis in Colorectal Cancer

机译:miR-142-3p通过PKM2介导的有氧糖醇分解在结肠直肠癌中调节细胞侵袭和迁移

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Decreased expression of miR-142-3p was observed in human cancers. However, the function and mechanism of miR-142-3p in human colorectal cancer remain obscure. The expressions of miR-142-3p in human colorectal cancer tissues and cell lines were measured by RT-qPCR. The effects of miR-142-3p on cell invasion and migration were detected by transwell assays. The efficiency of aerobic glycolysis was determined by glucose consumption and lactate production. Dual-luciferase reporter assays were performed to confirm the correlation between miR-142-3p and pyruvate kinase isozyme M2 (PKM2). The level of PKM2 was assessed by western blotting. Our results showed that the expression of miR-142-3p was decreased both in human colorectal cancer tissues and in cells. Overexpression of miR-142-3p in cell line attenuated colorectal cancer cell invasion and migration. About the underlying mechanism, we found that miR-142-3p modulated aerobic glycolysis via targeting pyruvate kinase M2 (PKM2). In addition, we demonstrated PKM2 and PKM2-mediated aerobic glycolysis contributes to miR-142-3p-mediated colorectal cancer cell invasion and migration. Hence, these data suggested that miR-142-3p was a potential therapeutic target for the treatment of human colorectal cancer.
机译:在人类癌症中观察到miR-142-3p的表达降低。然而,人结肠直肠癌miR-142-3p的功能和机制仍然模糊不清。通过RT-QPCR测量人结肠直肠癌组织和细胞系中miR-142-3p的表达。通过Transwell测定检测miR-142-3p对细胞侵袭和迁移的影响。通过葡萄糖消耗和乳酸产生来确定有氧糖酵解的效率。进行双荧光素酶报告器测定以确认miR-142-3p和丙酮酸激酶同工酶m2(pkm2)之间的相关性。通过蛋白质印迹评估PKM2的水平。我们的研究结果表明,人结直肠癌组织和细胞中的miR-14-3p的表达减少。细胞系中miR-142-3p的过度表达减毒结直肠癌细胞侵袭和迁移。关于潜在机制,我们发现MiR-142-3P通过靶向丙酮酸激酶M2(PKM2)调节有氧糖酵解。此外,我们证明了PKM2和PKM2介导的需氧糖酵解有助于miR-142-3p介导的结肠直肠癌细胞侵袭和迁移。因此,这些数据表明miR-142-3p是治疗人结直肠癌的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号